New Shockwave-Stent combo tackles tough leg artery blockages
NCT ID NCT05291247
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested a two-step treatment for severely calcified leg artery disease in 50 patients. First, a shockwave device cracks the hard calcium deposits, then a drug-coated stent is placed to keep the artery open. The goal was to see if this approach is safe and effective at maintaining blood flow for 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Shockwave intravascular lithotripsy device and a drug-eluting vascular stent
What this could lead to
If successful, this combination could offer a safer, more effective way to open severely calcified leg arteries, reducing the need for repeat procedures.
What could go wrong
This is a small, completed trial with 50 participants, so results may not apply to everyone. The procedure carries risks like vessel rupture, blood clots, or heart complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Klinikum Hochsauerland
Arnsberg, North Rhine-Westphalia, 59759, Germany
-
SRH Klinikum Karlsbad-Langensteinbach
Baden-Baden, Baden-Wurttemberg, 76307, Germany
-
St. Marien Hospital Lünen
Lünen, North Rhine-Westphalia, 44534, Germany
-
University Hospital Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany
-
University Hospital Essen
Essen, North Rhine-Westphalia, 45147, Germany
-
University Hospital LMU Munich
Munich, Bavaria, 80337, Germany